Long non-coding RNA TUG1 and its molecular mechanisms in polycystic ovary syndrome.

长链非编码 RNA TUG1 及其在多囊卵巢综合征中的分子机制。

  • 影响因子:4.18
  • DOI:10.1080/15476286.2020.1783850
  • 作者列表:"Li Y","Zhang J","Liu YD","Zhou XY","Chen X","Zhe J","Zhang QY","Zhang XF","Chen YX","Wang Z","Chen SL
  • 发表时间:2020-06-19

:Polycystic ovary syndrome (PCOS) causes anovulatory infertility in women of reproductive age, but etiopathogenesis of PCOS remains undetermined. Taurine up-regulated 1 (TUG1), an evolutionarily conserved long non-coding RNA, performs various biological functions; however, the role of TUG1 in PCOS remains unclear. Herein, TUG1 expression was assayed in granulosa cells (GCs) of 100 patients with PCOS and 100 control participants. Receiver operating characteristic (ROC) curve analysis was conducted to determine the diagnostic value of TUG1 in PCOS. TUG1 expression was also silenced in KGN cells to explore the role of TUG1 in cellular proliferation, apoptosis, cell-cycle progression, autophagy, and steroidogenesis. We found that TUG1 levels were dramatically increased in the PCOS group compared with those of the control group; this increased expression was related to a rising antral follicle count (R = 0.209, P < 0.001 versus control). The ROC curve indicated a significant separation between PCOS group and the control group (AUC: 0.702; 95% CI: 0.630-0.773; P < 0.001). TUG1 showed a predominantly nuclear localization in human GCs. TUG1 knockdown reduced cellular proliferation, and promoted MAPKs pathway-dependent apoptosis and P21-dependent autophagy, but may not affect cell-cycle progression. TUG1 knockdown increased aromatase expression and estradiol biosynthesis. Our results indicate that increased TUG1 expression in PCOS GCs may contribute to excessive follicular activation and growth, and may disrupt the selection of dominant follicle. Our study shows that TUG1 can be used as a diagnostic biomarker for PCOS.


: 多囊卵巢综合征 (PCOS) 导致育龄妇女无排卵性不孕,但 PCOS 的病因尚未确定。牛磺酸上调 1 (TUG1) 是一种进化上保守的长链非编码 RNA,具有多种生物学功能; 然而,TUG1 在 PCOS 中的作用仍不清楚。在此,检测了 100 例 PCOS 患者和 100 例对照组的颗粒细胞 (GCs) 中 TUG1 的表达。采用受试者工作特征 (ROC) 曲线分析确定 TUG1 在 PCOS 中的诊断价值。在 KGN 细胞中也沉默了 TUG1 的表达,以探讨 TUG1 在细胞增殖、凋亡、细胞周期进程、自噬和类固醇生成中的作用。我们发现与对照组相比,PCOS 组 TUG1 水平显著升高; 这种表达增加与窦卵泡计数增加有关 (R = 0.209,与对照组相比 P <0.001)。ROC 曲线显示 PCOS 组和对照组之间存在显著分离 (AUC: 0.702; 95% CI: 0.630-0.773; P <0.001)。TUG1 在人 GCs 中显示出主要的核定位。TUG1 敲除可减少细胞增殖,促进 MAPKs 通路依赖性凋亡和 P21-dependent 自噬,但可能不影响细胞周期进程。TUG1 敲除增加了芳香化酶的表达和雌二醇的生物合成。我们的结果表明,PCOS GCs 中 TUG1 表达增加可能导致卵泡过度激活和生长,并可能破坏优势卵泡的选择。我们的研究表明 TUG1 可以作为 PCOS 的诊断生物标志物。



作者列表:["Makrinou E","Drong AW","Christopoulos G","Lerner A","Chapa-Chorda I","Karaderi T","Lavery S","Hardy K","Lindgren CM","Franks S"]

METHODS:Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder amongst women of reproductive age, whose aetiology remains unclear. To improve our understanding of the molecular mechanisms underlying the disease, we conducted a genome-wide DNA methylation profiling in granulosa lutein cells collected from 16 women suffering from PCOS, in comparison to 16 healthy controls. Samples were collected by follicular aspiration during routine egg collection for IVF treatment. Study groups were matched for age and BMI, did not suffer from other disease and were not taking confounding medication. Comparing women with polycystic versus normal ovarian morphology, after correcting for multiple comparisons, we identified 106 differentially methylated CpG sites with p-values <5.8 × 10 that were associated with 88 genes, several of which are known to relate either to PCOS or to ovarian function. Replication and validation of the experiment was done using pyrosequencing to analyse six of the identified differentially methylated sites. Pathway analysis indicated potential disruption in canonical pathways and gene networks that are, amongst other, associated with cancer, cardiogenesis, Hedgehog signalling and immune response. In conclusion, these novel findings indicate that women with PCOS display epigenetic changes in ovarian granulosa cells that may be associated with the heterogeneity of the disorder.

翻译标题与摘要 下载文献
作者列表:["Vatopoulou A","Tziomalos K"]

METHODS::Introduction: Approximately 1% of adolescents have polycystic ovary syndrome (PCOS) and almost 40-70% of these patients are overweight or obese. Obese adolescents with PCOS have more severe insulin resistance and hyperandrogenemia, a more adverse lipid profile and a worse quality of life than normal-weight adolescents with PCOS. Accordingly, weight loss is an important component of the management of these patients.Areas covered: The authors discuss the different options for weight loss in obese adolescents with PCOS. Lifestyle changes appear to be effective but adherence to this intervention is suboptimal. There are also limited data regarding the optimal diet in this population. Few small studies have evaluated the effects of pharmacotherapy in these patients. Conflicting data have been reported regarding the effects of metformin on body weight. Notably, agents that have been approved for weight loss in adults have not been evaluated in adolescents with PCOS.Expert opinion: More studies are needed to identify the most appropriate diet for obese adolescents with PCOS. Well-designed randomized controlled studies are also needed to define the safety and efficacy of pharmacotherapy in this population.

翻译标题与摘要 下载文献
作者列表:["Ding Y","He P","Li Z"]

METHODS::Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. Although much is understood concerning the pathology of PCOS, further investigation into the influence of microribonucleic acids (miRNAs) on the proliferation of ovarian granulosa cells (GCs) is needed. This study investigated the role of specific miRNAs in ovarian dysfunction of PCOS and its effect on the proliferation of GCs. Initially, miRNA profiling was performed on the ovarian cortexes of 15 rats in which PCOS had been induced and 15 rats without PCOS (non-PCOS). This mechanical study was performed on ovarian GCs extracted from human chorionic gonadotrophin (hCG)-induced rats. Insulin was used to treat GCs to establish the PCOS cell model. Increased Equus caballus mir-9119 expression was observed and confirmed in the insulin-induced model of PCOS in GCs (GC-PCOS) as well as in the hCG-induced rats when compared to non-PCOS rats and cells. Observation and confirmation were carried out through both miRNA array and quantitative PCR. In contrast, downregulation of the nuclear factor kappa B (NFκB) p65 was observed in the PCOS cell model. Additionally, annexin V, FITC, and propidium iodide flow cytometry showed overexpression of miR-9119-induced apoptosis. In this study, we revealed that miR-9119 inhibition regulates p65 expression levels in insulin-treated GCs by binding to the 3'-untranslated of p65. Additionally, regulation of p65 expression was positively correlated with the expression of the double-stranded RNA endoribonuclease DICER. Moreover, RNA silencing/overexpression of p65 affected the functional role of miR-9119. In conclusion, GCs of PCOS, the expression of miR-9119, and targeted NFκB/p65-DICER axis are upregulated in order to maintain cell viability and prevent apoptosis, thereby promoting Anti-Müllerian hormone production in GCs. This study may provide a new understanding of the mechanism of GC dysfunction.

翻译标题与摘要 下载文献